Are you Dr. Eliaz?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 20 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
7064 Corline CT
Suite A
Sebastopol, CA 95472Phone+1 707-829-5900Fax+1 707-829-5282
Summary
- Dr. Isaac Eliaz, MD is a family physician in Sebastopol, California. He is currently licensed to practice medicine in California and Wisconsin. He is affiliated with Providence Santa Rosa Memorial Hospital.
Education & Training
- Valley Consortium for Medical Education Family MedicineResidency, Family Medicine, 1999 - 2000
- Tel Aviv University SacklerClass of 1988
Certifications & Licensure
- CA State Medical License 1992 - 2026
- WI State Medical License 2000 - 2005
Clinical Trials
- Effect of Modified Citrus Pectin on PSA Kinetics in Biochemical Relapsed PC With Serial Increases in PSA Start of enrollment: 2013 Jun 01
Publications & Presentations
PubMed
- 1 citationsModified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Long-Term Results of a Prospective Phase II Study.Daniel Keizman, Moshe Frenkel, Avivit Peer, Eli Rosenbaum, David Sarid
Nutrients. 2023-08-11 - 6 citationsThe potential roles of galectin-3 in AKI and CKD.Fengyun Wang, Lixin Zhou, Amity Eliaz, Chang Hu, Xinhua Qiang
Frontiers in Physiology. 2023-01-01 - 9 citationsModified Citrus Pectin Treatment in Non-Metastatic Biochemically Relapsed Prostate Cancer: Results of a Prospective Phase II StudyDaniel Keizman, Moshe Frenkel, Avivit Peer, Igal Kushnir, Eli Rosenbaum
Nutrients. 2021-11-28
Press Mentions
- Terumo Blood and Cell Technologies Collaborates with Eliaz Therapeutics in the Development and Commercialization of a Novel Therapeutic Apheresis Treatment for Acute Kidney Injury (AKI)July 27th, 2022
- Peptides: A Promising Alternative to Opioids - Experts SayMay 10th, 2022
- Landmark Clinical Study on Modified Citrus Pectin Treatment in Biochemically Relapsed Prostate CancerDecember 16th, 2021
- Join now to see all